Evidence map›Paper›PMID 32283767›Full record

ReviewInternational journal of molecular sciences2020

JNK Signaling in Stem Cell Self-Renewal and Differentiation.

Takashi Semba, Rachel Sammons, Xiaoping Wang, Xuemei Xie, Kevin N Dalby, Naoto T Ueno

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 83 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. World journal of experimental medicine · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Takashi SembaSection of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-1987-1645
Rachel SammonsDivision of Chemical Biology and Medicinal Chemistry, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA.ORCID 0000-0003-4211-0083
Xiaoping WangSection of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Xuemei XieSection of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Kevin N DalbyDivision of Chemical Biology and Medicinal Chemistry, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA.ORCID 0000-0001-9272-5129
Naoto T UenoSection of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-0166-7275
The University of Texas MD Anderson Cancer Center · USThe University of Texas at Austin · US

Funding

Nornicotine in smokeless tobacco as a precursor for carcinogen exposureR01CA180880 · NCI · UNIVERSITY OF MINNESOTA · PI STEPANOV, IRINA · 2014 to 2018
$2.4M
Enhancing anti-EGFR Therapeutic Efficacy in Inflammatory Breast CancerR01CA205043 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI UENO, NAOTO T. · 2017 to 2021
$1.8M
cAMP signaling in melanoma pathogenesis: Evidence for multiple microdomains playiK08CA160657 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI ZIPPIN, JONATHAN HALE · 2011 to 2015
$856k
Breast Cancer Research Foundation BCRF-17-161Cancer Prevention and Research Institute of Texas RP160657Cancer Prevention and Research Institute of Texas RP180880NCI NIH HHS R01 CA205043NIH HHS 1R01CA205043-01A1NIH HHS GM123252Welch Foundation F-1390
6 · The paper itself

Abstract

C-JUN N-terminal kinases (JNKs), which belong to the mitogen-activated protein kinase (MAPK) family, are evolutionarily conserved kinases that mediate cell responses to various types of extracellular stress insults. They regulate physiological processes such as embryonic development and tissue regeneration, playing roles in cell proliferation and programmed cell death. JNK signaling is also involved in tumorigenesis and progression of several types of malignancies. Recent studies have shown that JNK signaling has crucial roles in regulating the traits of cancer stem cells (CSCs). Here we describe the functions of the JNK signaling pathway in self-renewal and differentiation, which are essential features of various types of stem cells, such as embryonic, induced pluripotent, and adult tissue-specific stem cells. We also review current knowledge of JNK signaling in CSCs and discuss its role in maintaining the CSC phenotype. A better understanding of JNK signaling as an essential regulator of stemness may provide a basis for the development of regenerative medicine and new therapeutic strategies against malignant tumors.

Indexed as

Cell DifferentiationCell Self RenewalMAP Kinase Signaling SystemAnimalsCell Transformation, NeoplasticHumansJNK Mitogen-Activated Protein KinasesNeoplastic Stem CellsSignal TransductionStem Cell NicheStem CellsTumor MicroenvironmentJNK Mitogen-Activated Protein Kinasescancer stem cellC-JUN N-terminal kinaseJNKNOTCH1stem cellstem cell nichetumor microenvironmentWNT

Identifiers

PMID32283767
PMCPMC7177258
OpenAlexW3015997124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.